CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for inclisiran to prevent cardiovascular events in people with established atherosclerotic cardiovascular disease; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atherosclerotic Cardiovascular Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING